Intensified therapy for infants with acute lymphoblastic leukemia: Results from the Dana-Farber Cancer Institute Consortium [7]

Cancer

Volumn 83, Issue 5, 1998, Pages 1055-1057

  Szczepanski, T ^a   Pongers Willemse, M J ^a   Hahlen, K ^a   Van Dongen, J J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD33 ANTIGEN; CD65 ANTIGEN; IMMUNOGLOBULIN; MICROSOMAL AMINOPEPTIDASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; BLAST CELL; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN GENE; INFANT; LETTER; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0032168106     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19980901)83:5<1055::aid-cncr44>3.0.co;2-3     Document Type: Letter

References (6)